chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have had doarrhea since getting the vaccine 7 days ago; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (I have had doarrhea since getting the vaccine 7 days ago) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (I have had doarrhea since getting the vaccine 7 days ago). At the time of the report, DIARRHOEA (I have had doarrhea since getting the vaccine 7 days ago) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medication were not provided.  The treatment information was not provided.
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 13-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up).    Patient reference ID was mentioned. No concomitant medications was reported. It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses is as follows- 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. No treatment drug details was reported.
Child waiting with dad after vaccination. After 15min, father states that child coughed and started calling out and slowing falling over.  No loss of consciousness.  Father alerted staff. They were brought to a  patient room.  Doctort was alerted and was in the room with child. Child very pale. Skin cool and clammy. Decreased heart rate to 59  and blood pressure was 72/38.  Glucose was 89.   Blood pressure retaken after 5 min. (72/36) Pulse was 72. Color slowly returned to his face. Cool water and cookies given. Child eating and drinking. Father states, "He looks much better."   Episode lasted approximately 15 min.
Patient received the adult Pfizer bivalent dose of 30mcg, instead of 10mcg.
Reports within 10 minutes of receiving the vaccination felt lymph nodes throbbing under left arm . The pain traveled to the left elbow to the left wrist.. The next day 10:30 am, felt tachycardia, c/o blurred vision with a bad headache. Waited a bit for son to finish his activity and drove self to the Fire Station. HR was 258/minute can't remember diastolic BP but systolic BP 145. Received 2-doses of Adenosine on the way to the hospital. HR down to 145/minute in ER. Received Toradol for headache which was unrelieved. Received EKG, blood work, CT lungs. Resting HR on discharge in the 120's. 1/24/2021 Continued to feel poor with back pain making it difficult to breathe, body aches, headache and pain at the injection site. Was able to return to work on 1/26/2021
employee tested positive for COVID on 3/15 greater than 14 days after 2nd Pfizer vaccination Narrative: Employee tested positive for COVID greater thatn 14 days after 2nd dose of Pfizer vaccine
Received MMR yesterday at 11:30 AM. C/o swelling in legs (not abnormal because on disability) around 2 PM. C/o arms and hands and face swelling around 5:30 AM to 11 AM gone down about 1/2. Has not taken Benadryl. Has appt with MD at 1 PM. Advised to call back if any further reactions. She was given a steroid shot as well as Benadryl. Pt stated that the swelling has subsided and she is better. No further action taken.
Approx 5 hrs p/shot Pt started chilling & shaking & temp reached 102.8; Pt was hospitalized overnight & next day felt fine;
Nine days after receiving my booster on Oct 27th I started running a fever between 100-103 . So far it has been 3 months of fevers. My doctors have done all kinds of blood tests, blood cultures and xrays and ultra sound plus multiple CT Scans and come up empty for a way to explain it. I need to find out if others have reported this. I expect a call from someone from Pfizer.
Patient arrived to the outpatient vaccine clinic for her scheduled appointment. Immediately after receiving the vaccine, the patient felt chest pain, dizziness, and passed out. She had swelling of the tongue, lips, eyes, and throat.  Patient was admitted to the hospital and treated for anaphylaxis with epinephrine, benadryl, famotidine, methylprednisolone, Duoneb and tylenol.  Patient is currently still in the hospital but her condition is stable.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 05-SEP-2013 the patient was vaccinated with a dose of M-M-R II, lot # 1375AA, expiry date 26-AUG-2013 (dose, route, injection site not provided). No adverse effect reported. Additional information has been requested.
Within 15 minutes of receiving shot, patient reported she felt very lightheaded. She continued to feel that way, the whole day. The next day she felt fine. She also reported getting an itchy rash at the administration site that lasted about 1 week.
Patient received Pfizer COVID vaccine on 8/9/21 and 9/1/21. On 12/30/21, patient tested positive for COVID. On 1/7/22, patient admitted to our inpatient facility with acute hypoxic respiratory failure due to COVID-19 pneumonia. As of today (1/12/22), patient is still admitted in our med/surg unit.
Chronic Fatigue syndrome Ongoing. Had previously - 23 years ago. Tested positive for Epstein-Barr virus. Doctor said no treatment so not worth running more tests.
HAD 1st shot w/sore arm then all better HAD 2nd shot -next day back side of body muscles sore, Gone within 24 hrs. On Mar 11, 2021. Pt had bad headache, sinus congestion, chills, cough, Neck gland tender Mar 12- Tested + for Covid (Rapid Test) Mar14- Tested + for Covid with PCR test (swab) NOTE: Mar 3 Husband Tested + COVID (HAD NO VACCINES)
Joint Aches and pain. Fever of 99 for 2 days. Mild headache
PT COMPLAINS OF SKIN ERYTHEMA, SCALP IS HOT, NO ITCHING; EYES AND MOUTH ARE EXTREMELY DRY
Right after the vaccine, within 30 minutes I felt ?foggy?.  About 3 hours after the vaccine I felt fatigued and very bloated/stomachache. Within 24 hours I started my period early. Within 48 hours I had horrible stomach pain, from my ribs to my lower abdomen. Not to be confused with period cramps. Nauseating, doubled over, debilitating pain.  I?ve experienced Covid in feb 2021 and the side effects from the vaccine have felt like COVID did. It?s now been 72 hours and my stomach still hurts (especially when I eat or drink anything); I?m very fatigued when I move around (I worked out and had a very hard time during and after- and I work out 5 days a week minimum).  The only reason I didn?t go to the hospital from the pain is because I knew it had to be vaccine related and would pass - the pain wasn?t accompanied by fever, diarrhea or vomiting.
Dizziness, diarrhea repeatedly violently, vomiting repeatedly violently, headache, chills, fever of 101.2. Treated at clinic with e.k.g., chest exray, Zofran, Tylenol. Diarrhea and vomiting continue on 3rd day, recovering.
RN removed vial of what was thought to be a new box of COVID bivalent vaccines, which was in fact COVID monovalent box in the "COVID Bivalent" bright yellow bin. COVID box was not labeled "Monovalent" as it has been in the past when received from pharmacy, which indicated to RN that it was the bivalent, as it was also placed in the bivalent bin. RN pulled up all 6 doses up, and put them in the appropriate area for MA distribution. All COVID doses were distributed to patients. RN was notified that the clinic needed more bivalent doses, and went to the fridge to grab a vial of COVID bivalent vaccine to pull for distribution. Once at her desk, nurse noticed that the vial stated "COVID Vaccine", Not "COVID Bivalent". RN went back to verify that the box was also monovalent placed in the wrong bin. RN discussed with RN that it might have been monovalent distributed, RN confirmed that the vial used this morning for vaccines was pulled from the monovalent box that was labeled without "monovalent" and put in the COVID Bivalent bin.  RN and RN went to nursing supervisor to report the incident. Supervisor was onsite who was the previous Nurse Supervisor. Supervisor contacted IT in pharmacy to obtain a list of the patient's administered vaccines today. List retrieved. RN notified patients on 1/19 Per MD infectious disease head, 2 months until patients can receive bivalent dose.
Patient out of country and did not get 2nd vaccine as scheduled; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Patient out of country and did not get 2nd vaccine as scheduled) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Patient out of country and did not get 2nd vaccine as scheduled). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Patient out of country and did not get 2nd vaccine as scheduled) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided. The patient's second dose was scheduled on 24 Apr 2021 but was not taken due to his busy schedule. Enquired  whether he have to start the series all over or will it be effective even if we take the second dose.
Cellulitis, starting at injection site (left deltoid) and going down arm. Began day after immunization. Two days after immunization prescribed BACTRIM DS twice daily for 10 days.
Hives left hand, left cheek bone and then profound fatigue, bad insomnia and restlessness, severe bone pain in right foot and right arm; heart palpitations and fast heart rate with dizziness and nausea; headache; Day 8 started having muscle twitches and cranial/ear buzzing; Day 8 experienced severe malaise and nausea and lightheadness; Day 18 difficulty walking in straight line; muscle twitches with heart palpitations very bad in evening; localized headache at left temple area, stiff neck and shoulders; eye vision blurry with heavy floaters and eye socket pain; extremely vivid dreams
Patient reports noticing some red dry patches ( non itchy)  to all over body within 2 to 7 days of receiving vaccine. Patient is not sure if it is due to the vaccine or not. Patient was recommended to consult the doctor in regards to this. And pt was notified that we will report to VAERS.  Patient did not mention anything about doing any treatment.
Patient received Moderna vaccine, even though he is not >18 years of age.  This was an over-site; however, the patient tolerated the vaccine and no adverse events were experienced.
headaches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP), Program ID: A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headaches". Additional information: The reporter said he talked to 200 people who have a headache from that booster shot. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300086344 Same reporter/ drug/ event for different patients;
Chronic pain in shoulder. Pain 7/10 - worse w/ movement. In PT/TENS unit/improving.
fever of 100 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 100 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PYREXIA (fever of 100 F). On 18-Mar-2021, PYREXIA (fever of 100 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 100. On 18-Mar-2021, Body temperature: 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment for the event, included ibuprofen.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021.
After 18 hours following receiving the second dose of Moderna's Covid 19 vaccine, patient experienced dementia like symptoms including disorientation, nonsensical speech, tremors, unawareness of her surroundings, and inability to comprehend what was being to her and where she was. This lasted about 12 hours and then she had no recollection of her behavior and symptoms.
swollen armpit after Shingrix; This case was reported by a consumer and described the occurrence of swelling arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was unknown.   It was unknown if the reporter considered the swelling arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per vaccine indication. The patient received Shingrix and experienced swollen armpit. No other information was provided. The information regarding consent to follow up was not reported.
Seen in office 10/12/16 complaining of exacerbated eye blinking x 4 days. Resolved at visit 10/18/16.
pt recv vax 21AUG95 & 22AUG95 pt devel an inj site rxn characterized by warmth & extreme swelling;the swelling persisted for 3 days & resolved;this is one of two patients @ this site who exp above rxn p/receiving same lot#
Traveling hives. First appeared on left side of head. Disappeared.  Reappeared two days later on right side of face and neck. Disappeared. Reappeared on chest. Disappeared. Reappeared on back of neck. This went on for a couple of weeks.
MOTHER STATED THAT THE SAME DAY HER DAUGHTER RECEIVED VACCINATIONS HER RIGHT ARM BECAME SWOLLEN, RED, PAINFUL FROM ELBOW TO TOP OF SHOULDER SHE WAS THEN TAKEN TO EMERGENCY ROOM WHERE SHE RECEIVED CARE UNDER A PHYSICIAN WAS GIVEN STEROIDS AND WAS TOLD THAT SHE HAD A REACTION TO THE VACCINE SHE RECEIVED DOCUMENTED VACCINES THAT WERE GIVEN TO THE RIGHT ARM WERE KINRIX AND VARICELLA.
Fever, 99.9F body temp. Severe shivering. Lasted until 2:00 AM. Tiredness next 24 hours.
This spontaneous retrospective pregnancy report was received from a physician concerning to a female patient (age not reported). No concomitant medications, medical history nor concurrent conditions were reported. On an unknown date, while the patient was 8 months pregnant, she was vaccinated with a dose of GARDASIL 9 (Site, route, dose, lot number and expiration date not reported) for prophylaxis. The last menstrual period and estimated delivery date were not reported. On an unknown date, the patient delivered a baby (gender and fetal outcome were not reported).
Refridgeration excursions identified; No adverse event; Poor quality vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Sep-2022 at 3:58 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 15-Sep-2022 at 3:58 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    No concomitant information was reported. Injection site given as Deltoid. Dose/volume given as 0.5 There were excursions noted. No adverse reactions reported to reporters knowledge for patient. No treatment information was reported.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 7/31/2022 Discharge Date: 8/2/2022  PRESENTING PROBLEM: Pericardial effusion  Dyspnea, unspecified type    HOSPITAL COURSE: 89 yo man with hx of recent COVID, CAD, COPD, HFpEF, Crohn's, and chronic pericardial effusion, just discharged 7/30 for concern of progressive exertional dyspnea. He was Treated for both COPD exacerbation and heart failure exacerbation. Even with bronchodilators, steroids and excellent diuresis, his DOE continued raising the concern whether his pericardial effusion has some influence. He did not have tamponade physiology on serial echo. Patient was discharged home, stable but return with same concern. His O2 sats reported dropped to 82% with ambulation. On exam neither his heart failure nor COPD is presenting in acute exacerbation.  CTS is not going to do a pericardial window.  We will discharge home on home oxygen.
Patient stated that she experienced a droopy lip approximately 2-3 weeks after receiving the 2nd dose of the Moderna COVID-19 vaccine. She was seen at the emergency room where they prescribed her an antiviral along with steroids that she is currently taking.
9/26/2022, achy, runny nose and progressed to general body aches, fever and a cough, and I felt very foggy. When I realized that I had a temperature I went and tested. My husband tested positive on Sunday, 9/25/2022. I tested on 9/26 and 9/27 and it the test were negative. On 9/28/2022, I went to test at the urgent care and the result was positive and I was prescribed PAXLOVID. It took a good 2 weeks to recover. I felt terrible. I was extremely tired and kind of foggy for at least 3 weeks.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from Regulatory Authority. The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEVOTHYROXINE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 13May2022, outcome "recovering" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course- The patient started experiencing symptoms two weeks ago but tested negative on a rapid test. Later, the patient got a PCR test the next morning (day 1) and it came back positive. The patient  doctor started the medicine on Paxlovid the next day (day 2). Later, had a few days of unpleasant symptoms but started feeling better and testing negative on rapid tests on day 6, and finished course of Paxlovid on day 7. Per CDC guidelines, the patient continued masking (including at home) through day 10, and then dropped precautions at home. Later, the patient woke up on day 12 with slightly swollen lymph nodes and decided to take a rapid test. It came back positive. Facility where the most recent COVID-19 vaccine was administered was Other. The patient received any other vaccines within 4 weeks prior to the COVID vaccine. There was list of any other medications the patient received within 2 weeks of vaccination.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
24 hours later 99.5 temp. Flushed, pale, lethargic, eye lids swollen, loss of appetite, nausea, rash (no itch) raised and flat red bumps, started on trunk and by next day spread to limbs, neck (no face) temp up to 101.1.
Given Dose of HEPLISAV-B That Had Been Out of Temperature Range for 11 Hours; Initial Report Received on 02-Sep-2022  A pharmacist reported that a female patient (age, race, and ethnicity unknown) received a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization that had been out of temperature range for 11 hours.  Medical history, concomitant medications, and allergies at the time of vaccination were unknown.  On 01-Sep-2022, the patient received the first dose of HEPLISAV-B (Lot # 938793; expiration date 07-Oct-2023, NDC # unknown) intramuscularly in the left deltoid. The HEPLISAV-B had been out of temperature range for 11 hours. The patient did not report any adverse effects/reactions.  No further information was provided.  Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Pt came in 9 days after receiving the shot. He claimed that 1-2 days after receiving it he had severe pain in both hips and one leg. He described it as both a muscle pain and bone pain. I told him to go see his Dr about it.